No connection

Search Results

HTFL vs LFST

HTFL
Heartflow, Inc.
BEARISH
Price
$26.95
Market Cap
$2.31B
Sector
Healthcare
AI Confidence
85%
LFST
LifeStance Health Group, Inc.
NEUTRAL
Price
$6.40
Market Cap
$2.45B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
HTFL
--
LFST
320.0
Forward P/E
HTFL
-89.77
LFST
16.74
P/B Ratio
HTFL
7.65
LFST
1.63
P/S Ratio
HTFL
13.13
LFST
1.72
EV/EBITDA
HTFL
-34.43
LFST
34.04

Profitability

Gross Margin
HTFL
76.8%
LFST
32.37%
Operating Margin
HTFL
-36.13%
LFST
4.74%
Profit Margin
HTFL
-66.35%
LFST
0.68%
ROE
HTFL
-111.37%
LFST
0.65%
ROA
HTFL
-16.75%
LFST
0.73%

Growth

Revenue Growth
HTFL
40.5%
LFST
17.4%
Earnings Growth
HTFL
--
LFST
--

Financial Health

Debt/Equity
HTFL
0.07
LFST
0.31
Current Ratio
HTFL
5.2
LFST
1.65
Quick Ratio
HTFL
4.87
LFST
1.38

Dividends

Dividend Yield
HTFL
--
LFST
--
Payout Ratio
HTFL
0.0%
LFST
0.0%

AI Verdict

HTFL BEARISH

HTFL exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational inefficiency. While the company maintains a strong liquidity position (Current Ratio 5.20) and impressive revenue growth of 40.5%, these are offset by deep negative profit margins (-66.35%) and a high Price/Sales multiple of 13.13. The combination of heavy insider selling ($62.54M) and consistent earnings misses suggests a significant disconnect between analyst optimism and internal sentiment.

Strengths
Strong YoY revenue growth of 40.50%
High gross margins (76.80%) indicating a scalable product
Very low debt-to-equity ratio (0.07)
Risks
Critical financial health (Piotroski F-Score 1/9)
Severe profitability issues with -66.35% profit margins
Aggressive valuation (P/S 13.13) relative to earnings performance
LFST NEUTRAL

LFST presents a stable but precarious financial profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided for bankruptcy risk assessment. While the company has successfully transitioned toward profitability with a promising forward P/E of 16.74, it trades at a massive premium compared to its Graham Number ($1.33) and Intrinsic Value ($0.14). Strong revenue growth of 17.4% is offset by razor-thin profit margins (0.68%) and aggressive insider selling totaling $32.51M. The stock is currently a speculative play on earnings expansion rather than a value-driven investment.

Strengths
Low Debt/Equity ratio of 0.31 indicating manageable leverage
Consistent revenue growth of 17.4% YoY and Q/Q
Successful transition from historical losses to positive EPS
Risks
Extreme trailing P/E ratio of 320.00
Heavy insider selling totaling $32.51M in the last 6 months
Razor-thin net profit margins of 0.68%

Compare Another Pair

HTFL vs LFST: Head-to-Head Comparison

This page compares Heartflow, Inc. (HTFL) and LifeStance Health Group, Inc. (LFST) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile